May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elvina Almuradova: MSKCC Study Sheds Light on Treatment of HER2+ Node-Negative Breast Cancer
May 30, 2025, 15:37

Elvina Almuradova: MSKCC Study Sheds Light on Treatment of HER2+ Node-Negative Breast Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on LinkedIn:

“A recent MSKCC study (n=213) sheds light on one of oncology’s more nuanced challenges — how to treat patients with microinvasive, HER2+ node-negative breast cancer.
Key findings:
  • No difference in invasive disease-free survival (iDFS) between patients with 1–4 vs. ≥5 microinvasive foci
  •  No clear iDFS benefit from adjuvant chemotherapy + HER2-targeted therapy (CT/H2TT) in patients with ≥5 foci
And yet, prognosis was excellent overall, with a 5-year iDFS of 95%
More treatment ≠ , better outcome?”

Title: Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis

Authors: Celine Yeh, Rachel Han, Abha Kulkarni, Charlie White, Yuan Chen, Matthew G. Hanna, Edi Brogi, Andrew D. Seidman

You can read the Full Article on Nature Partner Journals Breast Cancer

Elvina Almuradova: MSKCC Study Sheds Light on Treatment of HER2+ Node-Negative Breast Cancer

More posts featuring Elvina Almuradova.